Several integral membrane proteins exhibiting undecaprenyl-pyrophosphate (C55-PP) phosphatase activity were previously identified in Escherichia coli that belonged to two distinct protein families: the BacA protein, which accounts for 75% of the C55-PP phosphatase activity detected in E. coli cell membranes, and three members of the PAP2 phosphatidic acid phosphatase family, namely PgpB, YbjG and LpxT. This dephosphorylation step is required to provide the C55-P carrier lipid which plays a central role in the biosynthesis of various cell wall polymers. We here report detailed investigations of the biochemical properties and membrane topology of the BacA protein. Optimal activity conditions were determined and a narrow-range substrate specificity with a clear preference for C55-PP was observed for this enzyme. Alignments of BacA protein sequences revealed two particularly well-conserved regions and several invariant residues whose role in enzyme activity was questioned by using a site-directed mutagenesis approach and complementary in vitro and in vivo activity assays. Three essential residues Glu21, Ser27, and Arg174 were identified, allowing us to propose a catalytic mechanism for this enzyme. The membrane topology of the BacA protein determined here experimentally did not validate previous program-based predicted models. It comprises seven transmembrane segments and contains in particular two large periplasmic loops carrying the highly-conserved active site residues. Our data thus provide evidence that all the different E. coli C55-PP phosphatases identified to date (BacA and PAP2) catalyze the dephosphorylation of C55-PP molecules on the same (outer) side of the plasma membrane.
Citation: Manat G, El Ghachi M, Auger R, Baouche K, Olatunji S, Kerff F, et al. (2015) Membrane Topology and Biochemical Characterization of the Escherichia coli BacA Undecaprenyl-Pyrophosphate Phosphatase. PLoS ONE 10(11): e0142870. https://doi.org/10.1371/journal.pone.0142870
Editor: Eric Cascales, Centre National de la Recherche Scientifique, Aix-Marseille Université, FRANCE
Received: September 22, 2015; Accepted: October 27, 2015; Published: November 11, 2015
Copyright: © 2015 Manat et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information file.
Funding: This work was supported by grants from the Agence Nationale de la Recherche (Bactoprenyl project, ANR-11-BSV3-002), the Belgian State-Federal Science Policy (InterUniversity Attraction Poles Program, iProS P7/44 project), the Centre National de la Recherche Scientifique, and the University of Paris Sud. F.K. is a research associate of the FRS-FNRS (Brussels, Belgium).
Competing interests: The authors have declared that no competing interests exist.
Undecaprenyl-phosphate (C55-P) is an essential lipid present in the bacterial cell membrane that plays a central role in the biosynthesis of various cell wall components such as the peptidoglycan, teichoic acids, and the O-antigen moiety of lipopolysaccharides [1, 2]. It indeed acts as a carrier and membrane anchor for the sugar and glycan chain building blocks of these cell envelope components [1, 3]. C55-P-linked intermediate precursors are synthesized on the cytoplasmic side of the membrane, which are then translocated by dedicated systems (flippases) to the periplasmic side of the membrane where subsequent biosynthetic steps and polymerization reactions occur. For instance, in the peptidoglycan pathway, MraY and MurG enzymes successively transfer phospho-N-acetylmuramoyl-pentapeptide (MurNAc-pentapeptide) and N-acetylglucosamine (GlcNAc) motifs, respectively, from the corresponding UDP-linked nucleotide precursors, onto the C55-P lipid, thereby generating the characteristic lipid II peptidoglycan precursor consisting of C55-PP-MurNAc(-pentapeptide)-GlcNAc (Fig 1). This intermediate is then translocated to the membrane outer leaflet by a flippase (several putative flippases have been identified [4, 5]), where the disaccharide-pentapeptide motifs are finally polymerized and cross-linked by transglycosylase and transpeptidase activities of the penicillin-binding proteins . At the end of these reactions, the carrier lipid is released in an undecaprenyl-pyrophosphate (C55-PP), “inactive” form which could not serve as glycan acceptor and should then be recycled to participate in new rounds of peptidoglycan (and other polymers) synthesis. This recycling process requires both a dephosphorylation step, to regenerate the C55-P active form, and a translocation step, to drive it back to the inner side of the membrane. The de novo synthesis of C55-P also results from the dephosphorylation of its precursor C55-PP, which itself is formed by the condensation of eight molecules of isopentenyl-pyrophosphate (C5-PP) with one molecule of farnesyl-pyrophosphate (C15-PP), a reaction catalyzed in the cytoplasm by the UppS synthase [6, 7] (Fig 1).
The C55-PP precursor is de novo synthesized by the UppS enzyme in the cytoplasm, from which it partitions in the inner side of the plasma membrane. Then, it must be dephosphorylated to be used as a lipid carrier for the biosynthesis of various cell-envelope polymers such as the peptidoglycan, as exemplified here. As discussed in the text, two different hypotheses can be envisaged for the dephosphorylation of the de novo-synthesized C55-PP, which are illustrated here. Once the glycan has been transferred onto an acceptor in the periplasm, the lipid carrier is released again in its pyrophosphate form, which must be dephosphorylated and shuttled back to the inner side of the membrane to be reused.
The fact that the C55-PP dephosphorylation reaction potentially occurs on both sides of the membrane suggested the existence of different C55-PP phosphatases, with either cytoplasm- or periplasm-orientated active sites, that should be specifically involved in the de novo synthesis or the recycling of the C55-P carrier lipid, respectively . The bacA gene was the first gene identified as encoding a bacterial C55-PP phosphatase . Its overexpression in Escherichia coli had been earlier shown to result in the cell resistance to bacitracin , an antibiotic known to tightly bind to the pyrophosphate group of C55-PP, thereby sequestrating and blocking the dephosphorylation of this carrier lipid precursor . The BacA protein (also designated as UppP), which is an integral membrane protein, was then purified to homogeneity and its C55-PP phosphatase activity was demonstrated in vitro . The successful inactivation of the bacA gene in the E. coli chromosome showed that this gene was not essential for growth and the detection of ca. 25% of residual C55-PP phosphatase activity in mutant cell membranes suggested that other cell proteins may exist that exhibit the same activity and could maintain the cell viability in these conditions. Several genes coding for members of the PAP2 phosphatase protein family were indeed subsequently identified in E. coli, namely pgpB, ybjG and yeiU, that all coded for integral membrane proteins endowed with C55-PP phosphatase activity . None of these genes was individually essential for growth and only the deletion of the three genes bacA, pgpB and ybjG yielded a lethal phenotype. A thermosensitive conditional strain BWTsbacA was constructed which lacked all of these genes in the chromosome but contained a copy of bacA on a pMAK705-derivative plasmid that could not replicate at 42°C. This mutant lysed when grown at this non permissive temperature, a phenomena which had been clearly correlated with the inhibition of C55-PP recycling and the resulting arrest of peptidoglycan biosynthesis .
The latter studies thus revealed that multiple C55-PP phosphatases, belonging to two unrelated BacA and PAP2 protein families, coexisted in E. coli, and that several orthologs from both families were also encountered in most other bacterial species. This raised the question of the physiological role of this redundancy. Different hypotheses can be proposed, as discussed in a recent review . First, it can be speculated that some of these phosphatases are really specific of C55-P metabolism and that some others have a distinct function but could accept C55-PP to some extent as an alternative substrate, due to a broad specificity. Also, as discovered recently for the YeiU C55-PP phosphatase, some of these proteins could potentially exert a dual function in vivo. The latter enzyme, renamed LpxT, was indeed shown to specifically transfer the phosphate group from C55-PP onto the lipid A moiety of lipopolysaccharides [12, 13]. That other members of this protein family could also act as phosphotransferases and be involved in different specific cell-envelope structure modifications is thus conceivable. Moreover, as mentioned above, the C55-PP dephosphorylation reaction is expected to occur on both sides of the membrane, i.e. in two different cell compartments, which also justify the requirement for multiple C55-PP phosphatase activities.
On which side of the plasma membrane and on which types of substrates are really working these enzymes in vivo were therefore crucial points to investigate. The membrane topology and biochemical properties of the E. coli PgpB protein were analyzed first . To precisely localize the active site of this enzyme, a topological map was established by using the β-lactamase fusion procedure and residues that are essential for the enzyme activity were identified by a site-directed mutagenesis approach. PgpB was shown to be constituted of six transmembrane segments and to have its N- and C-terminal ends in the cytoplasm and the active site located on the outer side of the membrane . This topology has been recently fully validated by the determination of the crystal structure of this E. coli enzyme . The pure PgpB protein was shown in vitro to exhibit a broad-range substrate specificity as it could efficiently dephosphorylate various lipid pyrophosphate molecules, including C55-PP . Tatar et al. analyzed to some extent the membrane topology of YbjG and YeiU proteins, the two other E. coli C55-PP phosphatases belonging to the PAP2 family, and they found that the active sites of these enzymes were orientated towards the periplasm, as it was the case for PgpB . This suggested that all these PAP2 phosphatases were involved in the recycling of C55-PP molecules formed in the periplasmic environment. It was thus tempting to speculate that the BacA phosphatase could be responsible for the dephosphorylation of the de novo synthesized C55-PP molecules that are generated by the UppS synthase in the cytosol. Using various modeling programs, several authors previously reported some predictions of the structural organization of the BacA protein in the membrane. In their 2007 paper, Tatar et al. predicted that the BacA active site should be in the cytosol . In 2013, Bickford and Nick went to the same conclusion and also predicted that BacA should contain seven transmembrane segments and have its C-terminal extremity in the periplasm . More recently, Chang et al. proposed a completely different model in which the active site was in the periplasm and the protein constituted of eight transmembrane segments with both its N- and C-terminal extremities in the cytosol . However, none of these models was supported by any experimental data and on which side of the membrane the BacA phosphatase exerts its activity still remained to be determined. In the present work, the membrane topology of the BacA protein was for the first time elucidated experimentally and the active site and substrate specificity of this enzyme were investigated in more detail using complementary in vitro and in vivo functional assays.
Materials and Methods
Undecaprenyl-pyrophosphate (C55-PP) and undecaprenyl-phosphate (C55-P) were provided by the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences. Farnesyl-pyrophosphate (C15-PP) and isopentenyl-pyrophosphate (C5-PP) were from Sigma and [14C]C5-PP was purchased from Perkin Elmer Life Sciences. Diacylglycerol-pyrophosphate was from Avanti Polar Lipids and phosphatidylglycerol-phosphate was synthesized by using purified E. coli PgsA enzyme, essentially as described by Lu et al. . n-dodecyl-β-D-maltoside (DDM) was purchased from Anatrace and isopropyl-β-D-thiogalactopyranoside (IPTG) from Eurogentec. C55-PP synthase UppS was purified as described before . DNA ligase and restriction enzymes were obtained from New England Biolabs, and DNA purification kits were from Promega and Macherey-Nagel. Synthesis of oligonucleotides and DNA sequencing were performed by Eurofins-MWG. All other materials were reagent grade and obtained from commercial sources.
Bacterial strains, plasmids, and growth conditions
The E. coli strains DH5α (Life Science Technologies, Inc.), BW25113 , and C43(DE3) (Avidis-France) were used as hosts for plasmids and for the overproduction of the BacA enzyme. The thermosensitive conditional mutant strain BWTsbacA that carries a triple chromosomal gene deletion (ΔbacA ΔybjG ΔpgpB::kan) and harbors a bacA-expressing plasmid pMAKbacA (CmR) whose replication is impaired at 42°C has been previously described . The pTrc99A vector was obtained from Amersham Biosciences and the pTrcBac30 derived plasmid expressing BacA with a N-terminal 6×His-tag was described previously . The pNF150 plasmid carrying the lac promoter, a fragment of the β-galactosidase gene and the mature form of the β-lactamase gene was obtained from J.-P. Bohin . 2YT rich medium was used for growing cells  and growth was monitored at 600 nm with a Shimadzu UV-1601 spectrophotometer. When required, ampicillin, kanamycin and chloramphenicol were added at final concentrations of 100, 50 and 25 μg.ml-1, respectively.
General DNA techniques and E. coli cell transformation
PCR amplification of genes from the E. coli chromosome was performed in a Thermocycler 60 apparatus (Bio-med) using the Expand-Fidelity polymerase from Roche. DNA fragments were purified using the Wizard PCR Preps DNA purification kit (Promega). Plasmid isolations were carried out by the alkaline lysis method and standard techniques for endonuclease digestions, ligation and agarose gel electrophoresis were performed as previously described . Transformation of E. coli cells with plasmid DNA was performed as described by Dagert and Ehrlich  or by electroporation.
Site-directed mutagenesis of residues identified as invariant or highly conserved in the BacA protein family was performed by using the « Quikchange II XL site-directed mutagenesis kit » from Stratagene® and appropriate oligonucleotides whose sequences are reported in S1 Table. These mutations were introduced directly in the pTrcBac30 expression plasmid and all of them were confirmed by sequencing of the entire bacA gene insert.
BacA protein membrane topology analysis
Transmembrane segments were predicted by using the TMAP program [25, 26] and a series of residues potentially localized within cytoplasmic or periplasmic hydrophilic regions were chosen as the junction sites for the construction of BacA-β-lactamase (BacA-BlaM) hybrid proteins, as follows. A series of truncated forms of bacA gene (at the 3’ end) were amplified from the E. coli chromosome using oligonucleotides listed in S1 Table. In all cases, the same forward primer (bacA-for) introduced a BamHI site 12 bp upstream from the initiation codon of bacA and the varying reverse primer introduced a KpnI site at the site of truncation. These PCR fragments were cleaved by BamHI and KpnI and inserted into the pNF150 plasmid vector cut by the same enzymes. In each case, the in-frame insertion led to IPTG-dependent expression of a protein consisting of the N-terminal fragment of BacA fused to the mature form (from HPETLVK to the end) of the β-lactamase via a short intermediary peptide AVPHAISSSPLR originating from the plasmid vector sequence. All of the plasmid constructs thus generated were verified by DNA sequencing. Each of them was then transformed into the DH5α strain and transformants were selected on kanamycin (pNF150 marker). The latter clones were subsequently tested for their susceptibility to ampicillin: appropriate dilutions of exponential phase cultures (ca. 200 cells) were plated onto 2YT plates containing or not ampicillin at 100 μg.ml-1 and growth was observed after 24 h of incubation at 37°C. The acquisition of ampicillin resistance was interpreted as the expression of a fusion protein with a periplasm-localized β-lactamase domain. To verify that all the types of transformants, in particular the ampicillin-sensitive ones, indeed expressed hybrid proteins, the ability of these strains to grow when patched (patch screening) on 2YT-agar containing ampicillin at 10 μg.ml-1 was controlled, as earlier described . Membrane extracts were prepared to determine the levels of β-lactamase and C55-PP phosphatase activities present in these transformants. Briefly, DH5α cells carrying these different plasmids were grown exponentially at 37°C in 2YT medium (0.5 liter cultures) and harvested in the cold at an OD600 of ca. 1. They were suspended in 25 mM Tris-HCl buffer, pH 7.2, supplemented with 150 mM NaCl, 5 mM 2-mercaptoethanol and 10% glycerol (buffer A), and were disrupted with a Vibracell 72412 sonicator (Bioblock). This suspension was then centrifuged for 30 min at 200,000 × g with a TL100 Beckman centrifuge and the pellets of membranes were washed three times with buffer A. The extraction and solubilization of membrane proteins was achieved by treatment of this membrane extract by the n-dodecyl-β-D-maltopyranoside (DDM) detergent at a final concentration of 1.5%. Protein concentrations were determined with the QuantiProBCA assay kit (Sigma) and bovine serum albumin as the standard. These membrane extracts were incubated for 120 min at 4°C under agitation and the β-lactamase activity was assayed by using nitrocefin as a substrate and the spectrophotometric procedure described by Calbiochem (France Biochem, Meudon, France). Membranes extracts were incubated at 25°C in 100 mM phosphate buffer, pH 7.0, containing 50 μg.ml-1 nitrocefin and the absorbance at 486 nm was monitored. The molar extinction coefficient of hydrolyzed nitrocefin at 486 nm is 20,500 M-1.cm-1. One unit of activity was defined as the hydrolysis of one nanomole of nitrocefin per min.
BacA functional complementation assay
Cells of the thermosensitive mutant strain BWTsbacA were made competent by treatment with calcium chloride and then transformed by the various plasmids to be tested. The mixture (cells and plasmid) was kept on ice for 1 h and then heated for 3 min at 42°C. 2YT medium was then added and the mixture was incubated for at least 2 h at 30°C. In each case, aliquots were plated onto two ampicillin-containing 2YT plates which were incubated at either 30°C or 42°C for 24 h. Functional complementation was judged by the capability of transformants to grow at both temperatures.
Expression and purification of the BacA protein
C43(DE3) cells carrying the pTrcBac30 plasmid (or one of its mutated derivatives) were used for the expression of the BacA protein in N-terminal His6-tagged form (Met-His6-Gly-Ser extension). Cells were grown in 2YT-ampicillin at 37°C and when the OD600 reached 0.7, the temperature of the culture was decreased to 22°C and protein expression was induced by addition of 1 mM IPTG. Incubation was continued overnight at this temperature and bacteria were harvested in the cold and washed with 25 mM Tris-HCl buffer, pH 7.2. Then, cells were resuspended in buffer A and were disrupted by sonication, as described above. This suspension was centrifuged for 30 min at 200,000 × g with a TL100 Beckman centrifuge and the pellets of membranes were washed three times with buffer A. The extraction and solubilization of membrane proteins was achieved by treatment of this membrane extract with the detergent DDM, as follows. BacA-containing membranes were resuspended in buffer A and DDM was added at a final concentration of 0.4% (8 mM). This mixture was incubated for 20 min at 4°C under agitation and then centrifuged as described above, yielding a first soluble extract (DDM1). The pellet was subjected to a second round of extraction in similar conditions except that the concentration of DDM was increased to 1.5% and that the incubation was prolonged overnight. A final centrifugation yielded a second soluble extract DDM2 which was then used for the purification of the BacA protein on nickel-nitrilotriacetate agarose (Ni2+-NTA, Qiagen). The extract was incubated overnight at 4°C under agitation with 2 ml of Ni-NTA polymer pre-equilibrated with 25 mM Tris-HCl buffer, pH 7.2, 300 mM NaCl, 5 mM 2-mercaptoethanol, and 20% glycerol (buffer B) supplemented with 10 mM imidazole. The mixture was then transferred into a Poly-prep chromatography column (Biorad) and the polymer was washed with buffer B containing 0.1% DDM. Elution of proteins was obtained by increasing progressively the concentration of imidazole from 10 to 300 mM. Aliquots from the different fractions were analyzed by SDS-PAGE as described previously . Fractions that contained essentially the BacA protein (> 90% purity) were subjected to an additional gel-fitration purification step on Superdex 200 (HiLoadTM 16/600 SuperdexTM 200) equilibrated in 0.1% DDM-containing buffer B. 2-ml fractions were collected and analyzed by SDS-PAGE. Pure fractions were pooled, eventually concentrated (30000 MWCO concentrator, Spin-XR UF) and dialyzed (12–14 MWCO hemi-permeable membrane, Spectra/PorR) overnight at 4°C against 25 mM Tris-HCl buffer, pH 7.2, containing 150 mM NaCl, 2 mM 2-mercaptoethanol, 5% glycerol and 0.1% DDM (buffer C). The BacA protein concentration was estimated by measurement of the absorbance at 280 nm, based on a theoretical molar extinction coefficient of 25,565 M-1.cm-1.
Thermal stability of the BacA protein was studied by differential scanning calorimetry (DSC) on a Microcal instrument. DSC measurements were carried out with a BacA sample (0.5 mg.ml-1) dialyzed against 20 mM potassium phosphate buffer (pH 7.5), 200 mM NaCl, 10 mM 2-mercaptoethanol, 10% glycerol and 0.02% DDM. Buffer solution from the dialysis bath was used as a reference. Scanning was performed from 20°C to 100°C at a scan rate of 60°C.h-1. Baseline subtractions and data analyses were performed using Origin 7.0 software supplied by the manufacturer (Microcal).
Synthesis of radiolabelled C55-PP substrate
[14C]C55-PP was synthesized using purified E. coli UppS synthase in a reaction mixture (300 μl) consisting in 100 mM Hepes buffer, pH 7.5, 100 μM C15-PP, 800 μM [14C]C5-PP (56 KBq), 0.5 mM MgCl2, 50 mM KCl, 0.1% Triton X-100, and enzyme (3 μg). The mixture was incubated at 25°C for 2 h and the completeness of the reaction was controlled by TLC analysis of an aliquot in conditions described below. [14C]C55-PP was then extracted from the reaction mixture by addition of 1 equivalent volume of 1 M pyridinium acetate, pH 4.5, and 2 volumes of butanol. It was recovered in the resulting upper phase and was subsequently dried under vacuum.
C55-PP phosphatase assay
The standard assay was performed in a reaction mixture (10 μl) containing 20 mM Tris-HCl buffer, pH 7.5, 150 mM NaCl, 0.1% (2 mM) DDM, 50 μM [14C]C55-PP (900 Bq), and enzyme. When the phosphatase activity was tested at different pH, the following appropriate buffers were used: glycine-HCl (pH 3), sodium acetate (pH 4–5), bis-Tris-HCl (pH 6–7) or Tris-HCl (pH 7.5–9). In all cases, appropriate dilutions of enzyme were used so that the consumption of the substrate was less than 30%. The reaction mixture was incubated for 10 min at 37°C and the reaction was stopped by freezing in liquid nitrogen. The radiolabelled substrate (C55-PP) and reaction product (C55-P) were separated by TLC on pre-coated plates of silica gel 60 (Merck) using 2,6-dimethyl-n-heptanone/acetic acid/water (8:5:1, v/v/v) as a mobile phase (Rf values of C55-PP and C55-P were 0.36 and 0.5, respectively). The radioactive spots were located and quantified with a radioactivity scanner (Rita Star, Raytest Isotopenmeβgeräte GmbH, Staubenhardt, Germany). The activity of BacA towards other (non-radiolabelled) substrates was determined by measuring the amounts of inorganic phosphate released during the reaction. The reaction mixture was as described above, in a final volume of 100 μl. After 10 min of reaction at 37°C, 0.9 ml of Malachite green (Biomol GreenTM, Enzo Life Sciences) was added and the released phosphate was quantified by measurement of the absorbance at 620 nm. All the above assays were performed at least in triplicate and deviations were < 10% in all cases. Data were fitted to the equation v = VmaxS/(Km + S) by the Levenberg-Marquardt method , where v is the initial velocity and S the substrate concentration and values ± standard deviations at 95% of confidence were calculated.
Biochemical characterization of the purified E. coli BacA protein
The E. coli BacA membrane protein (His-tagged form) was overproduced to high-levels in C43(DE3) cells following IPTG-induced gene expression at low temperature (22°C) from the pTrcBac30 plasmid. Previously established conditions allowing its efficient extraction and solubilization from cell membranes by the DDM detergent were used . The BacA protein was then successfully purified to homogeneity by performing two successive affinity chromatography and gel-filtration steps (Fig 2). The overall production and purification yield was very good for such an integral membrane protein, ca. 3 mg of protein per liter of culture. This final preparation also appeared homogeneous and devoid of aggregates, as judged by dynamic light scattering (DLS) analysis (Fig 2C).
The E. coli BacA protein (N-terminal His-tagged form) was overproduced, extracted from cells and purified on Ni2+-NTA agarose as described earlier . This purified material (200 mM imidazole-containing fraction) still contained some minor contaminant proteins, as judged by SDS-PAGE (panel B, first lane). It was further purified by gel filtration on a 120-ml HiLoad 16/600 Superdex 200 column, as described in the Materials and Methods (panel A). A single peak was observed, at an elution volume of 74.5 ml (main fraction: F38), corresponding to the BacA protein. It migrated with an apparent molecular mass of ca. 25 kDa on SDS-PAGE (12% gel, panel B), as observed previously . M, molecular mass standards used are indicated on the left (kilodaltons). Panel C, Size-distribution histogram of the purified BacA protein (fraction F38) deduced from DLS experiments, showing a monodisperse size distribution.
The optimal assay conditions, kinetic properties and substrate specificity of the purified C55-PP phosphatase were further investigated, using a previously developed assay that monitors the dephosphorylation of radiolabelled [14C]C55-PP by TLC analysis [8, 11]. The specific activity of our pure enzyme preparation that we initially determined in standard assay conditions was 1.3 μmol.min-1.mg of protein-1. Then, the effects of different parameters (pH, detergent concentration, temperature, and cations) on the enzyme activity were tested. Some of these enzyme properties were also recently analyzed by Chang et al. using C15-PP, a soluble C55-PP analogue, as the substrate . The effect of pH was determined in the 3–9 range using different buffers: BacA did not show significant activity at acid pH values < 5 and a plateau of maximal activity was observed between 5 and 7.5 (Fig 3A). Chang et al. also previously showed that the optimal pH of this protein was between 6.5 and 7. As a detergent is required for the solubilization of both the enzyme and the C55-PP substrate, the effect of varying the detergent concentration was also analyzed. The BacA activity appeared optimal at low DDM concentrations around 0.05–0.15% (1–3 mM), and it progressively decreased at higher concentrations (by ca. 50% at 10 mM), an effect likely due to the dilution of the C55-PP lipid substrate molecules in the detergent micelles rather than to an inhibition of the enzyme activity by this detergent (Fig 3B). To verify the latter assumption, we also tested the effect of another non-ionic detergent, lauryldimethylamine-oxide (LDAO), on the BacA activity towards C55-PP. A similar optimal activity was detected at 0.1% LDAO (4.3 mM) and the activity decreased progressively with the detergent concentration, as observed with DDM (data not shown). Moreover, when the C15-PP water-soluble substrate was used instead by Chang et al. , no effect of the detergent concentration was observed, thus also supporting the surface dilution effect of detergents when using a lipid substrate. The BacA activity was then tested at various temperatures ranging between 25 and 80°C. Quite interestingly, this protein appeared particularly thermostable, exhibiting an optimal activity at 65–70°C which was about 16 fold higher than at 37°C (Fig 3C). Differential scanning calorimetry (DSC) analyses confirmed that this protein was very stable, with a Tm of 73.5 (Fig 3D). As phosphatases sometimes require cations as cofactors, the effects of cations and EDTA on BacA activity were analyzed. Omitting MgCl2 in the standard reaction mixture did not affect the activity, suggesting that BacA does not require a (this) cation. However, the addition of 50 μM EDTA strongly inhibited the enzyme activity (95% inhibition) and at 1 mM of this chelator, the activity was further diminished but not totally abolished (2% residual activity) (Fig 3). This suggested that BacA required a cation for functioning and that this cation was already present in the purified enzyme stock. As no cations had been added to the buffers used for BacA purification, these cations, which remain to be identified, likely tightly bound to the protein when it was expressed in the cytosol and did not leave this position afterwards. Various cations (Mg2+, Mn2+, Zn2+, Co2+, Fe2+, Cu2+, and Ca2+) were then tested for their capability to restore the activity of the EDTA-pretreated enzyme. As shown in Fig 3E, the BacA activity lost after treatment with 50 μM EDTA was fully recovered following addition of MgCl2 and was only partially restored by MnCl2 (1 mM). CoCl2, FeCl2, ZnCl2, and CuCl2 did not yield significant activity. Surprisingly, in the same conditions CaCl2 not only restored the enzyme activity but also greatly enhanced it, by a ca. 9-fold factor. The latter effect was already maximal at 200 μM CaCl2 (Fig 3F). Chang et al. also recently reported a stimulating effect of Mg2+ and Ca2+ on the BacA activity using a C15-PP soluble substrate . No significant change of the BacA protein stability was observed following the addition of either EDTA or CaCl2, as judged by DSC analysis. In the standard assay conditions, typical Michaelis-Menten kinetics were observed and the Km for the physiological C55-PP substrate was estimated at 680 μM and the Vmax at 53 μmol.min-1.mg of protein-1 (kcat of about 27 s-1). The substrate specificity of this enzyme was also analyzed. BacA dephosphorylated both C55-PP and C15-PP substrates with similar efficiencies, when tested at the standard concentration of 50 μM (Table 1). Diacyl(C8)glycerol pyrophosphate also appeared to be a relatively good substrate. Isopentenyl-pyrophosphate (C5-PP), phosphatidylglycerol-phosphate and phosphatidic acid were not accepted at all (Table 1). No subsequent dephosphorylation of C55-P or C15-P products was observed (i.e. no spot corresponding to radiolabelled [14C]C55-OH was detectable by TLC), confirming that the BacA enzyme was specific for pyrophosphate substrates. This enzyme thus appeared more specific than the PgpB phosphatase which was shown to hydrolyze all of the different substrates we have tested here . A Km of 10.8 μM and a kcat of 2.1 s-1 were recently determined by Chang et al. for BacA when using the soluble C15-PP substrate . The concentration of 50 μM we used for this substrate was thus saturating for the enzyme. As mentioned above, when the natural C55-PP substrate was used instead, a 10-fold higher kcat value (27 s-1) was determined, showing that the BacA phosphatase exhibited a clear preference for C55-PP.
The effects on the BacA phosphatase activity of varying different parameters were analyzed: A, pH [pH 3 (glycine buffer), pH 4 and 5 (sodium acetate buffer), pH 6–7 (bis-Tris-HCl buffer), pH 7.5–9 (Tris-HCl buffer)]; B, DDM concentration; C, temperature. Panel D shows a typical DSC thermogram of the BacA protein (0.5 mg.ml-1) which displays a midpoint transition Tm of 73.5°C. Panel E shows the metal ion requirement of the BacA activity. The enzyme was treated or not with EDTA (50 μM) and then assayed in the presence of different divalent cations (Mg2+, Mn2+ or Ca2+) at a concentration of 1 mM. Panel F shows the effect on the BacA activity of varying the Ca2+ concentration (0–1 mM range).
The BacA activity was tested as described in Materials and Methods in the presence of 1 mM CaCl2, using the listed compounds at a 50 μM concentration. Results are expressed as mean ± standard deviation of three individual experiments. ND, no detectable activity, when up to 2 μg of pure BacA protein was used per assay.
Characterization of BacA active site by site-directed mutagenesis
Contrary to the YbjG, YeiU and PgpB proteins which were classified as phosphatases since a long time, based on their homology with other members of the PAP2 phosphatase family, no putative function had been assigned to BacA until we demonstrated its C55-PP phosphatase activity . Indeed, no characteristic signature was detected within the sequence of this protein that had been already observed in other proteins, although Bickford and Nick recently predicted that a conserved motif of BacA resembled the tyrosine phosphate phosphatase motif of the tumor suppressor, phosphatase and tensin homologue (PTEN) . BacA therefore constitutes its own family of phosphatases, which is specific to the bacterial world. As previously reported by other authors [17, 18], alignments of the sequences of BacA orthologues from various bacterial species highlighted two particularly well-conserved regions Val16-Ile33 and Ile160-Ala207 that we will designate here as the BacA1 and BacA2 motifs, respectively (Fig 4).
Alignments of these conserved motif sequences are shown for BacA orthologues from the following bacterial species: E. coli (eco), Staphylococcus aureus (sau), Corynebacterium striatum (cst), Mycobacterium tuberculosis (mtu), Streptomyces coelicolor A3 (sco), Neisseria meningitidis (nme), Pseudomonas aeruginosa (psaer), Campylobacter jejuni (cje), Aquifex aeolicus (aae), Flavobacterium johnsoniae (fjo), Buchnera sp. APS (bsp), Borrelia burgdorferi (bbu). Numbers indicate the position of residues in the E. coli protein. * indicates positions of single, fully-conserved residues, : indicates conservation between groups of strongly similar properties, and . indicates conservation between groups of weakly similar properties.
Several invariant residues were clustered within these motifs that could potentially be involved in substrate binding and/or catalysis. The specific role of these residues, in particular those possessing a polar side-chain, was investigated by using a site-directed mutagenesis approach. The Glu21, Ser26, Ser27 and His30 residues from the BacA1 motif, and the Gln164, Ser173, Arg174, Ser175, Arg189 and Ser196 residues from the BacA2 motif, were all mutated in alanine. Site-directed mutagenesis was performed directly on the expression plasmid pTrcBac30 and all the mutant proteins were produced and purified to homogeneity exactly as described for the wild-type protein, with quite similar purification yields, i.e. 2–4 mg of purified protein per liter of culture. The activity of these different BacA mutant proteins was then tested using both in vitro (enzymatic assay) and in vivo (functional complementation) assays. The specific enzyme activities of these proteins determined in vitro using the standard C55-PP phosphatase assay (Table 2) showed that with the exception of the Q164A, S175A and S196A mutants, which were only moderately affected (25–40% of the wild-type activity), all these mutations yielded dramatic losses of activity. This was particularly true for the four mutants E21A, S27A, S173A and R174A, which displayed only 1.4%, 0.013%, 2.2% and 0.13% of the wild-type activity, respectively. The mutations of Ser26, His30 and Arg189 residues also led to significant but less dramatic reductions of enzyme activity (6–15% of residual activity; Table 2). Chang et al. also analyzed recently the role of some of these conserved residues using a similar site-directed mutagenesis approach. The data they got are summarized in Table 2.
These different plasmids expressing wild-type or mutated copies of bacA were then tested for their capability to complement the BWTsbacA thermosensitive mutant strain. The three plasmids expressing the E21A, S27A and R174A mutant proteins could not complement this strain, i.e. did not restore its growth at 42°C, and the same was observed when IPTG inducer (0.05 or 0.5 mM) was added to further stimulate bacA gene expression from these constructs. All of the other plasmids fully complemented the thermosensitive mutant with or without IPTG. Interestingly, a very good correlation was observed between the in vivo (functional complementation) and in vitro (enzymatic activity) data. As shown in Table 2, plasmids that complemented the BWTsbacA mutant strain were those expressing a BacA mutant protein exhibiting at least 2% of the activity of the wild-type protein. All these data thus clearly showed that the His30 residue does not play a major role in the BacA reaction mechanism, contrary to what was earlier hypothesized . Our work instead highlighted the crucial implication of the Ser27 residue in the catalytic process, an invariant residue which had not been selected by Chang et al. in the course of their site-directed mutagenesis study . Another discrepancy observed between the two studies is that the latter authors reported only a minor effect for the E21A mutation (40% residual activity) while we observed it dramatically abolished the BacA activity both in vitro (1.4% residual activity) and in vivo (no complementation of the BWTsbacA mutant) (Table 2). Similar results were observed for the other mutations generated in common in the two studies (S173A, R174A, S175A and R189A) (Table 2). Then, to analyze whether the nature of the substrate could eventually explain some of the differences observed between the two studies, we also tested the activity of our BacA mutant proteins on the soluble C15-PP substrate. The S27A mutant did not exhibit detectable activity on this substrate. The H30A mutant appeared as active on C15-PP that it was on the C55-PP natural substrate, displaying ca. 6% of residual activity as compared to the wild type protein, a level higher than that reported by Chang et al. for this mutant (Table 2). Interestingly, we found that the E21A mutant was 20-fold more active on C15-PP than on C55-PP, which is in agreement with data from Chang et al. and suggests that this particular mutation also impacts in some way the enzyme substrate specificity.
Analysis of BacA protein membrane topology
As all the C55-PP phosphatases from the PAP2 family identified to date were shown to have a periplasm-orientated active site, on which side of the membrane is active BacA, which belongs to a distinct protein family, was thus a crucial question. As mentioned in the Introduction, several authors previously reported some predictions of the topology of this protein but their models differed completely and none of them was validated experimentally [17, 18]. We thus decided to determine the BacA topology experimentally by using the classical procedure we earlier used successfully for MraY and PgpB integral membrane proteins [14, 30]. It consisted in the construction of a series of BacA-BlaM hybrid proteins, i.e. C-terminally truncated forms of BacA of different sizes fused to the mature form of the β-lactamase, the latter protein being used as a reporter of the BacA transmembrane topology. Indeed, if the β-lactamase is fused to a point in BacA which is in a periplasmic environment, it will be able to hydrolyze ampicillin before this antibiotic can reach its target (PBP), thereby conferring ampicillin resistance to cells. However, if it is fused to a point in BacA which is in the cytoplasm, the β-lactamase domain could no more exert its protective effect and cells will remain ampicillin sensitive.
A series of 13 BacA residues (Gly42, Gly88, His110, Lys140, Glu143, Pro144, Gly176, Ala191, Glu194, Ser215, Thr244, Arg251, and the terminal Phe273 residue) potentially localized within cytoplasmic or periplasmic hydrophilic regions based on the topology models were chosen as the junction sites for the construction of the BacA-BlaM hybrid proteins. The corresponding truncated bacA genes were amplified by PCR using the oligonucleotides shown in S1 Table and these fragments were inserted in the pNF150 vector as a fusion with the gene encoding the mature form of β-lactamase, as described in Materials and Methods. DH5α cells carrying these different plasmids were then tested for their susceptibility to ampicillin (100 μg.ml-1), when plated at a low cell density (ca. 200 clones per plate). Fusions conferring ampicillin resistance in these conditions were those made at the positions of the residues Gly42, His110, Gly176, Ala191, Glu194, Ser215, and Phe273, demonstrating that these BacA residues were located in a periplasmic environment (Table 3). The other fusions at residues Gly88, Lys140, Glu143, Pro144, Thr244, and Arg251 did not confer ampicillin resistance and were thus considered to have the β-lactamase, and these residues of BacA, in a cytoplasmic environment (Table 3). To exclude the possibility that some of the fusions failed to confer ampicillin resistance because no hybrid protein was made, rather than because the fusion junction was intracellular, the specific activity of β-lactamase was determined in membrane extracts prepared from these different transformants. While no activity was detected in cells carrying the empty pNF150 vector or the vector carrying the entire bacA gene alone, all the transformants expressing a BacA-BlaM protein exhibited a significant level of β-lactamase activity (Table 3), demonstrating that all these fusions were produced and functional. Furthermore, the capability of all of these plasmids to confer ampicillin resistance at a high cell density was tested. Indeed, as described previously , ampicillin-induced lysis of some cells releases the intracellular β-lactamase which could then hydrolyze the antibiotic locally and allow the neighboring cells to grow. We found that all the transformants were able to grow when patched on 2YT-ampicillin medium, confirming the expression of a functional hybrid protein in all cases.
Truncated forms of the bacA gene were amplified by PCR by using the forward primer bacA-for and one of the reverse primers listed here whose sequences are reported in S1 Table. These fragments were inserted into the pNF150 vector and the resulting plasmids were transformed in the DH5α strain. The levels of C55-PP phosphatase and β-lactamase activities detected in membrane extracts of these transformants, as well as their susceptibility to ampicillin, were then determined.
All these data generated experimentally allowed us to draw a topological model that diverged significantly from the previously predicted models [17, 18]. In particular, contrary to what had been proposed, it consisted of seven and not eight transmembrane segments and consequently the C-terminal extremity of the protein was in the periplasm and not in the cytoplasm (Fig 5). The fact that the fusion of the entire bacA gene to the β-lactamase gene in the pNF150 vector (pBacATEM plasmid) yielded an enzymatically-active hybrid protein, as judged by a ca. 30-fold increase of the C55-PP phosphatase activity detected in cell membranes, which conferred high-level ampicillin resistance to cells, clearly demonstrated that the C-terminal residue of BacA (Phe273) was localized in the periplasm (Table 3). As a confirmation, the latter plasmid was also shown to fully complement the growth defect of the thermosensitive BWTsbacA mutant strain. None of the other hybrid proteins, and in particular the fusion at Arg251 that only lacks the last 22 residues of BacA forming the seventh transmembrane segment, yielded such an increase of membrane C55-PP phosphatase activity nor complemented the thermosensitive mutant strain, showing that the whole protein sequence is required for the enzyme activity (Table 3). In the topological model thus generated, the highly-conserved BacA1 and BacA2 signature motifs were both located on the periplasmic side of the plasma membrane: the BacA1 motif was found at the end of the first transmembrane segment and in the P1 periplasmic loop, and the larger BacA2 motif was located within the fifth transmembrane segment and P3 periplasmic loop (Fig 5).
This topological model was determined experimentally as described in Materials and Methods by using the β-lactamase as a reporter of the transmembrane topology of BacA. P1-P3: periplasmic domains; C1-C3: cytoplasmic domains. Transmembrane segments were predicted by the TMAP program [25, 26]. BacA residues colored in red and blue are invariant and highly-conserved residues, respectively. Stars indicate the residues that were used as junction points for the construction of the different BacA-BlaM hybrid proteins. Blue and green stars correspond to hybrid proteins that conferred and did not confer ampicillin resistance to cells when plated at a low cell density, respectively. The sequences of the two characteristic BacA motifs (BacA1 and BacA2) are shown in the two boxes (invariant residues are in capitals, h correspond to hydrophobic residues and x to any residue; numbers in superscript indicate the position of these residues in the E. coli BacA protein sequence).
Based on their membrane topology, the PAP2 C55-PP phosphatases PgpB, YbjG and YeiU/LpxT were expected to participate exclusively in the recycling of C55-PP molecules that are released on the outer side of the membrane [14, 16]. It was thus speculated that the BacA protein, which belonged to a distinct protein family and lacked any feature of a typical phosphatase, should have a cytoplasm-orientated active site and be responsible for the de novo synthesis of the carrier lipid [1, 16]. In fact, the membrane topology of BacA determined here experimentally clearly shows that this enzyme also exerts its activity in the periplasm, raising the question of the identity of the enzyme catalyzing the dephosphorylation of the de novo synthesized C55-PP molecules (Fig 1). Different hypotheses can be formulated: (i) either another non-identified enzyme(s) specifically catalyzes this reaction on the cytoplasmic side of the membrane, or (ii) any one of the BacA, YbjG or PgpB proteins can perform it in the course of de novo synthesis as well as recycling. The latter hypothesis implies that newly made C55-PP molecules first have to be flipped towards the periplasm to be dephosphorylated and then are translocated back to the cytoplasm to be glycosylated. As shown here and previously , the BacA phosphatase could efficiently dephosphorylate C15-PP which is one of the two soluble substrates used by the UppS synthase to generate the C55-PP carrier lipid precursor. This side activity of BacA would have been deleterious for cells if the BacA active site was exposed towards the cytoplasm. Indeed, a significant part of the pool of C15-PP would be converted into a C15-P end product that do not exist normally in cells, resulting in an inhibition of UppS activity, a decreased availability of C55-P and loss of cell viability. This raises the question of the substrate specificity of the “missing” putative C55-PP phosphatase acting on the cytoplasmic side of the membrane, if such an enzyme exists, which must be highly specific to C55-PP to avoid such a toxic effect. In fact, this important point can make us envisage the C55-P biosynthesis/recycling process differently. As mentioned above and described in Fig 1, we can indeed speculate that the dephosphorylation of both the recycled and the de novo-synthesized C55-PP molecules exclusively occurs on the outer side of the membrane. This model does not involve any C55-PP phosphatase working intracellularly. It will instead need a flip-flop of the newly made C55-PP molecules before they can be provided in the form of C55-P for the synthesis of cell-wall polymers. What could be considered at a first glance as a futile energy-consuming step could in fact have several advantages. There is no need in that case for a cytoplasmic C55-PP phosphatase and consequently no problem of toxicity resulting from a broad-range substrate specificity of this enzyme, as mentioned above. That the C55-PP synthesis and dephosphorylation reactions occur in two distinct and specific cell compartments, i.e. on the inner and outer sides of the membrane, respectively, would confer a driving force for unidirectional transbilayer movement of the lipid, i.e., an accumulation of C55-PP in the inner leaflet would favor its translocation towards the outer leaflet, with the opposite way for C55-P. In any case, the identity of a C55-PP and/or C55-P flippase remains a central issue. It was speculated that the polyprenol-sugar flippase (FtsW, MurJ, etc.) [4, 5] could play this role but we can also envisage that the integral membrane C55-PP phosphatases themselves could actively participate in this process, with or without the aid of a flippase. The fact that the C55-PP dephosphorylation reaction occurs on only one membrane side would be more adapted for the development of potential regulatory mechanisms adjusting the C55-P pool to the specific requirements of the biosynthesis of the different cell-wall polymers.
In contrast to the PAP2 C55-PP phosphatases, BacA enzymes do not belong to a family of characterized enzymes, neither structurally nor mechanistically. Sequence alignment of a great number of bacterial BacA homologues revealed two regions of the protein displaying a few invariant amino acid residues (Fig 4). In order to identify the catalytic site residues and to figure out the possible catalytic mechanism of BacA, we as well as Chang et al.  performed a structure-activity relationship analysis by using a site-directed mutagenesis approach. Discrepancies were observed between these two studies which may be explained by the fact that, to test the enzymatic activity of their mutated proteins in vitro, Chang et al. used C15-PP as a substrate, i.e. the soluble C55-PP precursor. In contrast, we used the natural substrate C55-PP that we synthesized by using the purified E. coli UppS enzyme. It is reasonable to figure out that the polyprenol chain itself may contribute in the recognition of the lipid by the membrane-embedded phosphatase. Moreover, we experienced, with the PgpB enzyme, that the kinetics of hydrolysis of C5-PP and C55-PP in vitro were strikingly different . Whereas the velocity of hydrolysis of C55-PP was decreasing as the amount of detergent was raising, that of C15-PP did not vary with the detergent concentration. The C55-PP hydrolysis is referred as surface dilution kinetic that likely reflects the dilution of the lipid substrate at the surface of the micelles , while C15-PP, despite its 15-carbon chain length aliphatic chain, likely remains in a soluble state in the aqueous environment. As a consequence, the turnover of hydrolysis of C15-PP was only dependent on its bulk concentration. Therefore, the mode of access of the lipid substrates to the active site of the phosphatases in the detergent-micelle model must be extremely different, with that of C55-PP likely being more physiologic than that of C15-PP. Our BacA mutagenesis study was strengthened by the fact that the results we obtained in vitro could be substantiated by a complementary in vivo analysis. Indeed, the functionality of our variants was tested via a complementation assay by using our conditional mutant strain BWTsbacA inactivated for all three C55-PP phosphatase-encoding genes and expressing bacA on a temperature-sensitive plasmid. We then demonstrated that the substitution of Glu21, Ser27 and Arg174 residues by an alanine almost completely inactivated the enzyme both in vivo and in vitro, without causing major structural instability. The substitutions of two other residues, His30 and Ser173, partially inactivated the enzyme (5–10% residual activity). In contrast, Chang et al. found that the mutations of His30, Ser173, Arg174 and Thr178 totally inactivated the enzyme when tested in vitro towards C15-PP . This finding led them to hypothesize that His30 residue may be a catalytic residue acting as the nucleophile in the attack on the phosphorus center to form a phospho-histidine intermediate . In fact, we here show that the His30 residue is not at all essential for catalysis, contrary to what would be expected for such a mechanism. Noteworthy, in contrast to the PAP2 enzymes, BacA phosphatase activity appeared to be dependent upon the presence of a cation as the enzyme was totally inhibited by EDTA . We also observed that Ca2+ was by far the most efficient cation in supporting BacA activity (about 7-fold higher activity in presence of Ca2+ as compared to Mg2+, and almost no detectable activity with other divalent cations). Such a metal ion requirement has been observed for the C55-PP synthase, UppS enzyme, where Mg2+ was found to be essential for the catalysis by facilitating the nucleophilic attack of the C15-PP allylic substrate by C5-PP and the release of its pyrophosphate group . The metal ion maintains the pyrophosphate moiety of the substrate in an optimal conformation for the enzyme catalysis. Based on the very strong decrease of BacA activity (0.013% of residual activity) that is observed following mutagenesis of the Ser27 residue, we suggest that this essential serine should act as a nucleophile residue in the attack of the C55-PP β-phosphorus atom, thereby yielding a phospho-seryl intermediate and releasing C55-P. The charged carboxyl group of the side chain of Glu21 residue may ensure the deprotonation of the hydroxyl group of the catalytic Ser27 residue to form a reactive oxyanion. This specific role proposed for Glu21 is supported by the enzymatic activity of the E21A mutant protein and by the optimal pH (5–7.5) of the BacA-catalyzed reaction which is compatible with the pKa of its charged group (4.07). Subsequently, the phospho-enzyme must be hydrolyzed through the action of an activated water molecule or another nucleophile, thus releasing inorganic phosphate or a phosphorylated acceptor molecule, respectively (Fig 6). The positively charged guanidino group of the Arg174 residue could be important in holding the pyrophosphate group of the lipid substrate. Future work and in particular attempts to trap such a covalently-bound phospho-enzyme intermediate, by using the different mutants and/or substrate analogues, will provide valuable insights into the catalytic mechanism of this enzyme. Of course the elucidation of the three-dimensional structure of the BacA protein will constitute a major challenge and milestone, and the acquired knowledge on the purification, biochemical properties and stability of this protein will likely be very helpful in this regard.
The present mechanism is based on the results of the structure-activity relationship analysis developed in this work. Two residues Glu21 and Ser27 that are essential for the catalytic process were identified, whose mutation into alanine yielded BacA enzymes with dramatically altered activities (1.4% and 0.013% of residual activity, respectively). The Ser27 residue has a hydroxyl group that can act as a nucleophile when deprotonated by the carboxyl group of Glu21 residue, the latter group displaying a negative charge at the pH that is optimal for BacA activity. The deprotonated Ser27 then initiates a nucleophilic attack on the β-phosphorus center of C55-PP substrate to form a phospho-serine enzyme intermediate, a reaction releasing the C55-P product. A subsequent attack by a water molecule releases the second inorganic phosphate product.
We thank Magali Aumont-Nicaise from the microcalorimetry platform of IBBMC for assistance with the DSC analyses.
Conceived and designed the experiments: FK TT DML AB. Performed the experiments: GM MEG RA KB SO AB. Analyzed the data: TT DML AB. Contributed reagents/materials/analysis tools: RA. Wrote the paper: DML AB.
- 1. Manat G, Roure S, Auger R, Bouhss A, Barreteau H, Mengin-Lecreulx D, et al. Deciphering the metabolism of undecaprenyl-phosphate: the bacterial cell-wall unit carrier at the membrane frontier. Microb Drug Resist 2014; 20(3):199–214. pmid:24799078
- 2. Bouhss A, Trunkfield AE, Bugg TD, Mengin-Lecreulx D. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol Rev 2008; 32(2):208–33. pmid:18081839
- 3. Hartley MD, Imperiali B. At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl-phosphates. Arch Biochem Biophys 2012; 517(2):83–97. pmid:22093697
- 4. Sham LT, Butler EK, Lebar MD, Kahne D, Bernhardt TG, Ruiz N. Bacterial cell wall. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis. Science 2014; 345(6193):220–2. pmid:25013077
- 5. Mohammadi T, van Dam V, Sijbrandi R, Vernet T, Zapun A, Bouhss A, et al. Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane. Embo J 2011; 30(8):1425–32. pmid:21386816
- 6. Kato J, Fujisaki S, Nakajima K, Nishimura Y, Sato M, Nakano A. The Escherichia coli homologue of yeast RER2, a key enzyme of dolichol synthesis, is essential for carrier lipid formation in bacterial cell wall synthesis. J Bacteriol 1999; 181(9):2733–8. pmid:10217761
- 7. Apfel CM, Takacs B, Fountoulakis M, Stieger M, Keck W. Use of genomics to identify bacterial undecaprenyl pyrophosphate synthetase: cloning, expression, and characterization of the essential uppS gene. J Bacteriol 1999; 181(2):483–92. pmid:9882662
- 8. El Ghachi M, Bouhss A, Blanot D, Mengin-Lecreulx D. The bacA gene of Escherichia coli encodes an undecaprenyl pyrophosphate phosphatase activity. J Biol Chem 2004; 279(29):30106–13. pmid:15138271
- 9. Cain BD, Norton PJ, Eubanks W, Nick HS, Allen CM. Amplification of the bacA gene confers bacitracin resistance to Escherichia coli. J Bacteriol 1993; 175(12):3784–9. pmid:8389741
- 10. Siewert G, Strominger JL. Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls. Proc Natl Acad Sci U S A 1967; 57(3):767–73. pmid:16591529
- 11. El Ghachi M, Derbise A, Bouhss A, Mengin-Lecreulx D. Identification of multiple genes encoding membrane proteins with undecaprenyl pyrophosphate phosphatase (UppP) activity in Escherichia coli. J Biol Chem 2005; 280(19):18689–95. pmid:15778224
- 12. Touzé T, Tran AX, Hankins JV, Mengin-Lecreulx D, Trent MS. Periplasmic phosphorylation of lipid A is linked to the synthesis of undecaprenyl phosphate. Mol Microbiol 2008; 67(2):264–77. pmid:18047581
- 13. Valvano MA. Undecaprenyl phosphate recycling comes out of age. Mol Microbiol 2008; 67(2):232–5. pmid:18086187
- 14. Touzé T, Blanot D, Mengin-Lecreulx D. Substrate specificity and membrane topology of Escherichia coli PgpB, an undecaprenyl pyrophosphate phosphatase. J Biol Chem 2008; 283(24):16573–83. pmid:18411271
- 15. Fan J, Jiang D, Zhao Y, Liu J, Zhang XC. Crystal structure of lipid phosphatase Escherichia coli phosphatidylglycerophosphate phosphatase B. Proc Natl Acad Sci U S A 2014; 111(21):7636–40. pmid:24821770
- 16. Tatar LD, Marolda CL, Polischuk AN, van Leeuwen D, Valvano MA. An Escherichia coli undecaprenyl-pyrophosphate phosphatase implicated in undecaprenyl phosphate recycling. Microbiology 2007; 153(Pt 8):2518–29. pmid:17660416
- 17. Bickford JS, Nick HS. Conservation of the PTEN catalytic motif in the bacterial undecaprenyl pyrophosphate phosphatase, BacA/UppP. Microbiology 2013; 159(Pt 12):2444–55. pmid:24068241
- 18. Chang HY, Chou CC, Hsu MF, Wang AH. Proposed carrier lipid-binding site of undecaprenyl pyrophosphate phosphatase from Escherichia coli. J Biol Chem 2014; 289(27):18719–35. pmid:24855653
- 19. Lu YH, Guan Z, Zhao J, Raetz CR. Three phosphatidylglycerol-phosphate phosphatases in the inner membrane of Escherichia coli. J Biol Chem 2011; 286(7):5506–18. pmid:21148555
- 20. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97(12):6640–5. pmid:10829079
- 21. Loubens I, Debarbieux L, Bohin A, Lacroix JM, Bohin JP. Homology between a genetic locus (mdoA) involved in the osmoregulated biosynthesis of periplasmic glucans in Escherichia coli and a genetic locus (hrpM) controlling pathogenicity of Pseudomonas syringae. Mol Microbiol 1993; 10(2):329–40. pmid:7934824
- 22. Miller JH. Experiments in Molecular Genetics. In: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; 1972:431–5.
- 23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; 1989.
- 24. Dagert M, Ehrlich SD. Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene 1979; 6(1):23–8. pmid:383576
- 25. Persson B, Argos P. Topology prediction of membrane proteins. Protein Sci 1996; 5(2):363–71. pmid:8745415
- 26. Persson B, Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 1994; 237(2):182–92. pmid:8126732
- 27. Broome-Smith JK, Tadayyon M, Zhang Y. β-lactamase as a probe of membrane protein assembly and protein export. Mol Microbiol 1990; 4(10):1637–44. pmid:2077355
- 28. Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol 1973; 80(4):575–99. pmid:4204102
- 29. Press WH, Flannery BP, Teukolsky SA, Wetterlink WT. Numerical recipes: the art of scientific computing, pp. 521–528. Cambridge University Press, Cambridge, UK. 1986.
- 30. Bouhss A, Mengin-Lecreulx D, Le Beller D, van Heijenoort J. Topological analysis of the MraY protein catalysing the first membrane step of peptidoglycan synthesis. Mol Microbiol 1999; 34(3):576–85. pmid:10564498
- 31. Carman GM, Deems RA, Dennis EA. Lipid signaling enzymes and surface dilution kinetics. J Biol Chem 1995; 270(32):18711–4. pmid:7642515
- 32. Guo RT, Ko TP, Chen AP, Kuo CJ, Wang AH, Liang PH. Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis. J Biol Chem 2005; 280(21):20762–74. pmid:15788389